Non-COVID point-of-care (POC) testing continued its upward trajectory, increasing by mid-single digits, and the segment remains a critical driver of diagnostic innovation globally.

The Nikkei 225 now sits just beneath the 37,750-point plateau and it may extend its gains on Thursday. Japan Stock Market May Test Resistance At 38,000 Points | Nasdaq Skip to main content ...

As Point Of Care testing becomes integrated into more clinical trials, three expert Biomedical Scientists explore where, how and why it should be used by pharma.

Covid-19 Update: Four new deaths have been reported over the past 24 hours, with one each in Delhi, Tamil Nadu, Kerala and Maharashtra. The country's active Covid-19 cases have increased to 3,961 ...

COVID-19 cases in India rise to 3,395; Delhi woman among 4 dead in 24 hours, 68 test positive in Maharashtra — 10 points According to data from the Ministry of Health, the number of active COVID ...

The results suggest that use of self-collection test kits could be considered in safety-net settings with low participation in cervical cancer screening programs, reported Jane R. Montealegre, PhD ...

Ovulation test kits are more accurate when you have a regular cycle because it’s easier to predict the midway point of your cycle. But ovulation testing can still work if you have an irregular ...

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such ...